Skip to content
10-Q

Quarterly Report

60 DEGREES PHARMACEUTICALS, INC. SXTP SXTPW

0001554855-25-002032

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 13, 2025 4.23M sh
Shares Diluted Q3 2025 · Sep 30, 2025 3.68M sh
Shares Diluted Q3 2025 · Sep 30, 2025 488.65K sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 2.15M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 287.53K sh
Capex Q3 2025 · Sep 30, 2025 $60K
Capex Q3 2025 · Sep 30, 2024 $103.77K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$5.16M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$4.01M
Short Term Investments Q3 2025 · Sep 30, 2025 $0
Short Term Investments Q3 2025 · Dec 31, 2024 $1.73M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $4.12M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $1.66M
Stockholders Equity Q3 2025 · Sep 30, 2025 $4.43M
Stockholders Equity Q3 2025 · Dec 31, 2024 $4.04M
Current Liabilities Q3 2025 · Sep 30, 2025 $2.2M
Current Liabilities Q3 2025 · Dec 31, 2024 $1.66M
Total Liabilities Q3 2025 · Sep 30, 2025 $2.34M
Total Liabilities Q3 2025 · Dec 31, 2024 $1.8M
Current Assets Q3 2025 · Sep 30, 2025 $6.31M
Current Assets Q3 2025 · Dec 31, 2024 $5.39M
Total Assets Q3 2025 · Sep 30, 2025 $6.69M
Total Assets Q3 2025 · Dec 31, 2024 $5.76M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.66
Eps Diluted Q3 2025 · Sep 30, 2025 −$4.65
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$2.92
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$21.74
Eps Basic Q3 2025 · Sep 30, 2025 −$0.66
Eps Basic Q3 2025 · Sep 30, 2025 −$2.92
Eps Basic restated Q3 2025 · Sep 30, 2024 −$4.65
Eps Basic restated Q3 2025 · Sep 30, 2024 −$21.74
Sga Expense Q3 2025 · Sep 30, 2025 $1.51M
Sga Expense Q3 2025 · Sep 30, 2025 $4.81M
Sga Expense Q3 2025 · Sep 30, 2024 $1.22M
Sga Expense Q3 2025 · Sep 30, 2024 $3.42M
Rd Expense Q3 2025 · Sep 30, 2025 $809.78K
Rd Expense Q3 2025 · Sep 30, 2025 $1.47M
Rd Expense Q3 2025 · Sep 30, 2024 $940.06K
Rd Expense Q3 2025 · Sep 30, 2024 $4.37M
Net Income Q3 2025 · Sep 30, 2025 −$2.32M
Net Income Q3 2025 · Sep 30, 2025 −$5.93M
Net Income Q3 2025 · Sep 30, 2024 −$2.16M
Net Income Q3 2025 · Sep 30, 2024 −$5.9M
Operating Income Q3 2025 · Sep 30, 2025 −$2.33M
Operating Income Q3 2025 · Sep 30, 2025 −$5.84M
Operating Income Q3 2025 · Sep 30, 2024 −$2.12M
Operating Income restated Q3 2025 · Sep 30, 2024 −$7.65M
Gross Profit Q3 2025 · Sep 30, 2025 −$100.09K
Gross Profit Q3 2025 · Sep 30, 2025 $41.07K
Gross Profit Q3 2025 · Sep 30, 2024 $23.61K
Gross Profit restated Q3 2025 · Sep 30, 2024 $99.25K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $537.69K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $661.01K
Cost Of Revenue Q3 2025 · Sep 30, 2024 $111.69K
Cost Of Revenue Q3 2025 · Sep 30, 2024 $266.69K
Revenue Q3 2025 · Sep 30, 2025 $437.6K
Revenue Q3 2025 · Sep 30, 2025 $702.09K
Revenue Q3 2025 · Sep 30, 2024 $135.29K
Revenue restated Q3 2025 · Sep 30, 2024 $365.94K